Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

513.12
-7.8800-1.51%
Post-market: 513.310.1900+0.04%19:30 EDT
Volume:415.57K
Turnover:215.18M
Market Cap:22.01B
PE:18.36
High:528.02
Open:523.23
Low:512.29
Close:521.00
52wk High:609.35
52wk Low:302.19
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.96
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.44
PE(LYR):18.42

Loading ...

United Therapeutics CEO Martine Rothblatt Disposes of USD 5.18 Million in Common Shares

Reuters
·
Jul 09

What United Therapeutics (UTHR)'s Centralized LungFX EVLP FDA Approval Means For Shareholders

Simply Wall St.
·
Jul 08

United Therapeutics is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

United Therapeutics CEO Martine Rothblatt Sells 9,500 Common Shares for $5.21 Million

Reuters
·
Jul 07

RBC Capital Raises United Therapeutics Price Target to $704 From $701, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

United Therapeutics CEO Martine Rothblatt Disposes of 8,500 Common Shares Worth $4.63 Million

Reuters
·
Jul 03

United Therapeutics Acquires Thymmune Therapeutics for USD 140 Million Upfront

Reuters
·
Jul 02

United Therapeutics Corp - Deal Valued at $140 Mln Cash Plus up to $160 Mln in Earn-outs by 2031

THOMSON REUTERS
·
Jul 02

14 Value Stocks of Companies Primed for Rapid Growth Through 2028

Dow Jones
·
Jul 02

United Therapeutics CEO Martine Rothblatt Reports Disposal of 9,500 Common Shares Valued at $5.16 Million

Reuters
·
Jul 01

United Therapeutics IPF Opportunity Outweighs Base Business Risks, UBS Says

MT Newswires Live
·
Jul 01

United Therapeutics Shareholders Endorse 2026 Governance and Pay

TIPRANKS
·
Jun 30

United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of 9,500 Common Shares for $5.12 Million

Reuters
·
Jun 30

United Therapeutics Shareholders Approve 2026 Stock Incentive Plan at Annual Meeting

Reuters
·
Jun 30

United Therapeutics Wins FDA Approval for Lungfx Lung Perfusion Device

Reuters
·
Jun 29

United Therapeutics Corp - Lung Bioengineering Expects to Add Lungfx to Services in 2027

THOMSON REUTERS
·
Jun 29

United Therapeutics Corporation Announces FDA Approval of the Lungfx™ Device for Centralized Ex Vivo Lung Perfusion

THOMSON REUTERS
·
Jun 29

United Therapeutics CEO Martine Rothblatt Disposes of USD 4.99 Million in Common Shares

Reuters
·
Jun 26

United Therapeutics Chairperson and CEO Martine Rothblatt Disposes of Common Shares Worth $5.08 Million

Reuters
·
Jun 24

United Therapeutics CFO James Edgemond sells 8,750 shares worth $4.7 million

Reuters
·
Jun 24